Clinical Trials for Immunotherapy

Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma

NCT ID: NCT06755567

This clinical trial is studying how well a new method using MRI images can help predict how patients with head and neck squamous cell carcinoma respond to neoadjuvant therapy, which includes treatm...

A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus

NCT ID: NCT06741982

This clinical trial is looking at a new treatment approach for patients with head and neck squamous carcinoma, a type of cancer in the head and neck area that can be surgically removed. The study i...

Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study

NCT ID: NCT06743555

The SAVED LUNG study is a clinical trial designed to explore the safety and feasibility of either observing patients or performing standard surgery for those with operable Stage II-III non-small ce...

Phase I/II Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer

NCT ID: NCT06743581

This clinical trial is studying a new treatment approach for early-stage non-small cell lung cancer (NSCLC), which is a type of lung cancer. Researchers are looking at the safety and effectiveness ...

Customized Circulating Tumor DNA Testing for Cervical Cancer Recurrence Surveillance and Treatment Decisions

NCT ID: NCT06649838

This clinical trial is looking at a new way to monitor and treat cervical cancer using a test called ctDNA, which looks for tiny pieces of cancer DNA in the blood. The goal is to create a personali...

Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

NCT ID: NCT06734702

This clinical trial is investigating a new treatment approach for people with locally advanced non-small cell lung cancer (NSCLC) that cannot be surgically removed. The study is comparing the effec...

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

NCT ID: NCT04821778

This clinical trial is studying new treatment options for patients with esophageal or esophagogastric junction cancer that cannot be surgically removed. The researchers are exploring the combinatio...

Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors

NCT ID: NCT06302062

This clinical trial is testing a new type of treatment called tumor-associated lymph node T cell therapy for patients with advanced solid tumors that have not responded to standard treatments. The ...

Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC

NCT ID: NCT06603402

This clinical trial is investigating a new treatment approach for patients with locally advanced esophageal squamous cell carcinoma (ESCC), a type of cancer affecting the esophagus. The study aims ...

Effect of G-CSF on MDSC and Cancer Stem-cells Interactions in Non-small Cell Lung Cancers (CIRCUIT)

NCT ID: NCT06711770

The CIRCUIT trial is studying how a medication called Granulocyte Colony Stimulating Factor (G-CSF) affects certain cells in the blood of patients with non-small cell lung cancer (NSCLC). This type...

Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases

NCT ID: NCT06702826

This clinical trial is investigating the use of a medication called Cadonilimab, combined with a type of targeted radiation therapy known as stereotactic radiation therapy (SRT), for patients with ...

TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC

NCT ID: NCT06676449

This clinical trial is looking to find out if a combination of immunotherapy, a type of treatment that helps the immune system fight cancer, along with a special kind of radiation therapy that spar...

SBRT Combined with Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy

NCT ID: NCT06676722

bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC

NCT ID: NCT06061276

This clinical trial is exploring a new treatment approach for patients with a specific type of liver cancer called hepatocellular carcinoma (HCC), particularly those with large tumors. The research...

68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.

NCT ID: NCT06608160

This clinical trial is studying a new imaging test called 68Ga-grazytracer PET to help doctors better understand a condition known as pseudoprogression in lung cancer patients who have received imm...

Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer

NCT ID: NCT06600841

This clinical trial is studying a new treatment approach for women with recurrent platinum-resistant ovarian cancer, a type of cancer that does not respond to standard platinum-based chemotherapy. ...

Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC

NCT ID: NCT06510660

This clinical trial is studying a new treatment approach for patients with a type of esophageal cancer called esophageal squamous cell carcinoma (ESCC) that cannot be surgically removed. The trial ...

Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma

NCT ID: NCT06571396

This clinical trial is studying the safety and effectiveness of immunotherapy-based treatments for patients with hepatocellular carcinoma (HCC), which is a type of liver cancer. The researchers aim...

Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma

NCT ID: NCT06567600

This clinical trial is looking at a new treatment approach for patients with advanced intrahepatic cholangiocarcinoma, a type of liver cancer that cannot be removed by surgery. Researchers want to ...

bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma

NCT ID: NCT06070636

This clinical trial is exploring a new treatment approach for patients with a specific type of liver cancer called infiltrative hepatocellular carcinoma (HCC). The study is testing a combination of...